gptkbp:instance_of
|
gptkb:legal_case
|
gptkbp:bfsLayer
|
5
|
gptkbp:bfsParent
|
gptkb:AMX-0035
|
gptkbp:aims_to
|
treatment efficacy
|
gptkbp:business_model
|
gptkb:battle
|
gptkbp:collaborated_with
|
international researchers
|
gptkbp:collaborates_with
|
gptkb:NHS
|
gptkbp:collaborations
|
academic institutions
|
gptkbp:conducted
|
gptkb:healthcare_organization
hospital settings
clinical research teams
informed consent.
|
gptkbp:contributed_to
|
COVID-19 treatment guidelines
|
gptkbp:data_privacy
|
gptkb:battle
|
gptkbp:focuses_on
|
gptkb:COVID-19
|
gptkbp:has_backstory
|
gptkb:battle
|
gptkbp:has_impact_on
|
gptkb:healthcare_organization
|
https://www.w3.org/2000/01/rdf-schema#label
|
CENTAUR trial
|
gptkbp:involves
|
randomized controlled trial
standard care
|
gptkbp:is_analyzed_in
|
statistical methods
adverse events
|
gptkbp:is_documented_in
|
clinical trial registries
|
gptkbp:is_evaluated_by
|
cost-effectiveness
safety and efficacy
|
gptkbp:is_influenced_by
|
previous studies
|
gptkbp:is_informed_by
|
patient feedback
|
gptkbp:is_monitored_by
|
independent committee
|
gptkbp:is_part_of
|
global health initiatives
larger research initiative
COVID-19 research efforts
|
gptkbp:is_related_to
|
RECOVERY trial
|
gptkbp:is_reviewed_by
|
peer reviewers
|
gptkbp:is_supported_by
|
gptkb:charitable_organizations
government grants
pharmaceutical companies
|
gptkbp:is_tested_for
|
Phase 2
|
gptkbp:launched
|
gptkb:2020
|
gptkbp:led_to
|
Professor Peter Horby
|
gptkbp:measures
|
clinical outcomes
|
gptkbp:outcome
|
quality of life
mortality rate
hospitalization duration
|
gptkbp:participants
|
multiple countries
|
gptkbp:population
|
adults
|
gptkbp:published_by
|
medical journals
|
gptkbp:receives_funding_from
|
gptkb:government_agency
|
gptkbp:registration
|
gptkb:Clinical_Trials.gov
|
gptkbp:reports_to
|
gptkb:media_outlets
scientific conferences
regulatory authorities
|
gptkbp:result
|
gptkb:2021
|
gptkbp:sponsor
|
gptkb:University_of_Oxford
|
gptkbp:status
|
gptkb:battle
|
gptkbp:student_enrollment
|
completed
|
gptkbp:targets
|
hospitalized patients
|
gptkbp:uses
|
gptkb:dexamethasone
|
gptkbp:utilizes
|
placebo control
|